Interestingly, by comparing tumor growth of CD1d-expressing and CD1d-deficient tumor cells in NKT-deficient transgenic knockout (KO) models, we have uncovered important differences in the regulation of these cells by type I and type II NKT cells. This evidence concerns the gene CD1D and neoplasm.